Results 251 to 260 of about 349,459 (384)

Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder [PDF]

, 2001
D. Elmer Johnson, Jeffrey N. Epstein, L. Randolph Waid, Patricia K. Latham, Konstantin Voronin, Raymond F. Anton   +5 more
openalex   +1 more source

Sex differences in self‐reported attention‐deficit/hyperactivity disorder symptoms in clinical and population‐based cohorts

JCPP Advances, EarlyView.
There is an apparent gender paradox in ADHD; the childhood prevalence is higher in males than females but adult females with ADHD are reporting more severe impairment. We found that the relative difference in symptom levels between individuals with and without ADHD was larger in females than males, both in a clinical sample and in the general ...
Berit S. Solberg, Maj‐Britt Posserud, André Høberg, Johanne T. Instanes, Liv G. Kvalvik, Amalie Austgulen, Ammal Khan, Astri J. Lundervold, Anne Halmøy, Rolf Gjestad, Kari Klungsøyr, Jan Haavik   +11 more
wiley   +1 more source

Correction to "Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer's disease". [PDF]

Alzheimers Dement
europepmc   +1 more source

Investigating Emotional Interference as a Potential Endophenotypic Marker in Attention-deficit Hyperactivity Disorder: A QEEG Study. [PDF]

Indian J Psychol Med
Leon C, Kaur S, Batabyal T, Tayade P, Sagar R, Sharma R.   +5 more
europepmc   +1 more source

The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients [PDF]

, 2001
Andrew Adesman
openalex   +1 more source

Preregistration of high‐quality protocols in pharmacoepidemiology research

JCPP Advances, EarlyView.
Abstract Pharmacoepidemiology studies are an important complement to Randomized Clinical trials, but such studies face several challenges, such as confounding and selective reporting. How to best address confounding has been discussed in detail for many years.
Henrik Larsson, Zhang Chang, Kenneth K. C. Man   +2 more
wiley   +1 more source

Attention-Deficit/Hyperactivity Disorder as a Mediating Variable for Invalid Baseline Profiles on the ImPACT. [PDF]

Healthcare (Basel)
Petrossian A, Kelly LA, Casas RN, Twyford JM, McCrea MA, McAllister T, Broglio SP, Benjamin H, Buckley T, Duma S, Goldman J, Hoy A, Jackson J, Kaminski T, Master C, Miles C, Port N, Susmarski A.   +17 more
europepmc   +1 more source

The efficacy of neurofeedback in the management of children with attention deficit/hyperactivity disorder [PDF]

, 2001
Lola Baydala, Erik Wikman
openalex   +1 more source

Molecular genetics of attention deficit hyperactivity disorder.

Psychiatric Clinics of North America, 2010
S. Faraone, E. Mick
semanticscholar   +1 more source

A comprehensive longitudinal analysis of changes during Attention Deficit Hyperactive Disorder pharmacological treatments: Relationships between clinical measures, QbCheck and Conners CPT‐II

JCPP Advances, EarlyView.
Abstract Background This study aims to evaluate the clinical value of using QbCheck in routine Attention Deficit Hyperactive Disorder (ADHD) clinics by investigating longitudinal inter‐domain relationships between objective neurocognitive outcomes of QbCheck and subjective clinical outcomes: ADHD core symptoms, impairment and quality of life (QoL ...
Seungjae Lee, Renee Testa, Beth Johnson, David Coghill   +3 more
wiley   +1 more source